Trials / Completed
CompletedNCT03922633
A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants
A Phase 1 Clinical Study of a Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- EA Pharma Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics after a single intravenous dose of E3112 in Japanese healthy adult male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E3112 | Intravenous infusion. |
| OTHER | Placebo | Intravenous infusion. |
Timeline
- Start date
- 2019-04-22
- Primary completion
- 2020-05-20
- Completion
- 2020-10-01
- First posted
- 2019-04-22
- Last updated
- 2021-03-15
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03922633. Inclusion in this directory is not an endorsement.